| 영문 | antiglobulin antibody | 한글 | 항글로불린항체 |
|---|---|---|---|
| 설명 | 항체에 대한 항체, 즉 특정 항체와 결합할 수 있는 항체. 대개 인간의 항체를 쥐에 주사하여 쥐로 하여금 인간 항체에 대한 항체를 만들게 한다(쥐에 있어서는 인간의 항체도 외부에서 들어온 물질이므로). 이것은 여러 가지 실험에서 인간의 특정항체를 검출하는데 이용한다. |
||
| 영문 | antibody | 한글 | 항체 |
|---|---|---|---|
| 설명 | 사람의 몸에서 면역에 관계하는 물질. 외부에서 들어온 물질과 꼭 맞게 결합을 하여서 그 물질의 생물학적 활동을 억제하거나 파괴하거나 사람의 다른 면역세포로 하여금 공격하기 용이하게 해주는 기능을 가지고 있다. 항체는 면역글로부린이라는 것으로 이루어져 있고 그 형태에 따라 IgA, IgE, IgG, IgD등으로 나눈다. |
||
| 영문 | white blood cell(WBC), leukocyte | 한글 | 백혈구 |
|---|---|---|---|
| 설명 | 혈액내에 골수구계세포와 림프계세포, 단핵구계세포를 모두 통틀어 말한다. 백혈구의 증가가 있으면 대개 감염이 있거나, 혹은 탈수현상이 있음을 의미한다. 또한 지나친 백혈구수의 감소는 인체내 면역기능이 떨어져 있음을 의미하며, 다른 질병에 의해 나타나는 이차적인 현상이 아닌지 꼭 진단을 받아보아야 한다. |
||
| 영문 | mast cell | 한글 | 비만 세포 |
|---|---|---|---|
| 설명 | 동물의 결합 조직 가운데 널리 분포하는 세포. 결합조직과 점막조직 내에 있는 호염기성 색소로 이염색성(metachromasia)을 나타내는 과립을 가진 방추형의 세포에 작은 둥근 핵을 가진다. 비만세포의 표면에는 IgE에 대한 수용체가 존재하며, 수용체에 결합한 IgE 분자들끼리 다가의 항원에 의해 서로 연결되면 비만세포 과립탈출 반응이 일어나, 히스타민, 세로토닌, 헤파린 등의 화학전달 물질이 방출되어, 즉시형 알레르기 반응 등의 증상을 일으킨다. 피부, 장막, 혈관 주위, 점막 주변에 있다. |
||
| ARFC | active rosette-forming T-cell; autologous rosette-forming cell |
|---|---|
| ACA | abnormal coronary artery; acrodermatitis chronica atrophicans; acute cerebellar ataxia; adenocarcino... |
| CFC | capillary filtration coefficient; colony-forming capacity; cardiofaciocutaneous [syndrome]; chlorofl... |
| MC | mass casualties; mast cell; Master of Surgery [Lat. Magister Chirurgiae]; maximum concentration; Med... |
| AFC | adult foster care; antibody-forming cell |
| AFC | Antibody-forming cell |
|---|---|
| CAFC | Cobblestone area forming cell |
| TRFC | Total rosette forming cell |
| ARFC | active rosette forming cell |
| HPFC | haemolytic plaque forming cell |
| antibody-forming cell | <immunology> B-cells (plasma cells) that are dedicated to producing secreted antibodies. (09 Feb 1998) |
|---|---|
| burst forming unit | <haematology> A bone marrow stem cell lineage detected in culture by its mitotic response to erythropoietin and subsequent erythrocytic differentiation in about 12 mitotic cycles into erythrocytes. (18 Nov 1997) |
| maltotriose-forming amylase | <enzyme> Also carries out transglycosylation, forming p-nitrophenyl alpha-maltotetraoside from maltotetraose and p-nitrophenyl alpha-d-glucopyranoside Registry number: EC 3.2.1.- Synonym: g3-amylase (26 Jun 1999) |
| channel forming ionophore | <chemistry> An ionophore that makes an amphipathic pore with hydrophobic exterior and hydrophilic interior. most known types are cation selective. (18 Nov 1997) |
| gram-positive endospore-forming bacteria | <microbiology> Bacteria that form endospores and are gram-positive. Representative genera include bacillus, clostridium, micromonospora, saccharopolyspora, and streptomyces. (12 Dec 1998) |
| gram-positive endospore-forming rods | <microbiology> Rod-shaped bacteria that form endospores and are gram-positive. Representative genera include bacillus and clostridium. (12 Dec 1998) |
| rosette-forming cells | T lymphocytes with an affinity for sheep erythrocytes and which, when suspended in serum, bind the uncoated, nonsensitised erythrocytes in a rosette formation. (05 Mar 2000) |
| colony-forming unit | <cell biology> An individual cell which is able to clone itself into an entire colony of identical cells. Irradiated mice can have their immune systems reconstituted by the injection of bone marrow cells from a nonirradiated animal. The injected cells form colonies in the spleen (hence s), each colony representing the progeny of a pluripotent stem cell. Operationally, therefore, the number of colony-forming units is a measure of the number of stem cells. Acronym: CFU (09 Oct 1997) |
| colony-forming units assay | A cytologic technique for measuring the functional capacity of stem cells by assaying their activity. (12 Dec 1998) |
| plaque-forming unit | <virology> Number of infectious virus particles or Ig producing cells per unit volume. See: plaque assay. <microbiology> Refers to any entity which can give rise to a plaque. For example: if a phage stock solution has 1010 pfu/ml, it means that every ml of this stock has 1010 phage particles which can form plaques. This (pfu/ml) is the conventional way to refer the concentration of a phage preparation. Compare: CFU. (10 Oct 1997) |
| spleen focus-forming viruses | Murine leukaemia viruses that are replication-defective and rapidly transforming. The envelope gene plays an essential role in initiating erythroleukaemia, manifested by splenic foci, splenomegaly, and polycythemia. Spleen focus-forming viruses are generated by recombination with other viral types including friend p (polycythemia), friend a (anaemia), rauscher, and cas (from wild mice at lake casita, california). (12 Dec 1998) |
| endospore-forming bacteria | A group of rods or cocci whose taxonomic affinities are uncertain. They form endospores, thick-walled bodies formed within the vegetative cells of certain bacteria, able to withstand adverse environmental conditions for prolonged periods. (12 Dec 1998) |
| focus-forming assay | <investigation> A lab technique used to find out if a particular piece of DNA contains oncogenes (genes which are associated with cancer). This is done by putting the DNA into animal cells which normally show contact inhibition, or which stop growing when they come into physical contact with other cells or reach a certain density in the culture. If the cells lose contact inhibition and form areas of densely-packed cells (called foci) after receiving the DNA, it means that the DNA did contain oncogenes. (05 Jan 1997) |
| focus-forming unit | A measurement of the concentration of live virus in a given amount of fluid. This is measured by spreading a known amount of the fluid over a layer of cultured cells which are infected by the virus, then counting the number of areas in the culture which look infected. (09 Oct 1997) |
| forming face | The side of the Golgi apparatus which faces the rough endoplasmic reticulum, where vesicles budding off of the rough endoplasmic reticulum fuse to the Golgi apparatus. Also called the cis side of the Golgi apparatus. (09 Oct 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|